Specifically, in our study population there were no significant differences regarding age, gender, diabetes, peripheral vascular disease (PVD) or EF, all of which could potentially impact GDF15 expression and are themselves known risk factors negatively impacting outcomes. Here, GDF15 is linked to peripheral vascular disease.